What is a stock summary page? Click here for an overview.
Business Description
Brooks Laboratories Ltd
NAICS : 325412
SIC : 2834
ISIN : INE650L01011
Compare
Compare
Traded in other countries / regions
533543.India IPO Date
2011-09-05Description
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.52 | |||||
| Interest Coverage | 1.81 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.08 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | -2.9 | |||||
| 3-Year FCF Growth Rate | -104.3 | |||||
| 3-Year Book Growth Rate | -7.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.79 | |||||
| 9-Day RSI | 40.03 | |||||
| 14-Day RSI | 40.5 | |||||
| 3-1 Month Momentum % | -43.34 | |||||
| 6-1 Month Momentum % | -33.83 | |||||
| 12-1 Month Momentum % | 4.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 52.69 | |||||
| Days Sales Outstanding | 71.86 | |||||
| Days Payable | 90.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -0.65 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.27 | |||||
| Operating Margin % | 2.07 | |||||
| Net Margin % | -21.77 | |||||
| FCF Margin % | -10.72 | |||||
| ROE % | -30.24 | |||||
| ROA % | -21.44 | |||||
| ROIC % | 2.53 | |||||
| 3-Year ROIIC % | -22.26 | |||||
| ROC (Joel Greenblatt) % | -76.25 | |||||
| ROCE % | -27.59 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.93 | |||||
| PB Ratio | 4.7 | |||||
| Price-to-Tangible-Book | 4.71 | |||||
| EV-to-EBIT | -16.65 | |||||
| EV-to-EBITDA | -18.63 | |||||
| EV-to-Revenue | 3.43 | |||||
| EV-to-FCF | -30.22 | |||||
| Price-to-GF-Value | 0.9 | |||||
| Price-to-Median-PS-Value | 1.17 | |||||
| Price-to-Net-Current-Asset-Value | 46.65 | |||||
| Earnings Yield (Greenblatt) % | -6 | |||||
| FCF Yield % | -3.19 | |||||
| Forward Rate of Return (Yacktman) % | -13.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Brooks Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 944.202 | ||
| EPS (TTM) (₹) | -7.95 | ||
| Beta | 1.32 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.44 | ||
| Volatility % | 76.03 | ||
| 14-Day RSI | 40.5 | ||
| 14-Day ATR (₹) | 9.729487 | ||
| 20-Day SMA (₹) | 109.574 | ||
| 12-1 Month Momentum % | 4.81 | ||
| 52-Week Range (₹) | 73.25 - 198.86 | ||
| Shares Outstanding (Mil) | 29.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brooks Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brooks Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Brooks Laboratories Ltd Frequently Asked Questions
What is Brooks Laboratories Ltd(NSE:BROOKS)'s stock price today?
The current price of NSE:BROOKS is ₹106.36. The 52 week high of NSE:BROOKS is ₹198.86 and 52 week low is ₹73.25.
When is next earnings date of Brooks Laboratories Ltd(NSE:BROOKS)?
The next earnings date of Brooks Laboratories Ltd(NSE:BROOKS) is .
Does Brooks Laboratories Ltd(NSE:BROOKS) pay dividends? If so, how much?
Brooks Laboratories Ltd(NSE:BROOKS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers